Survey: Californians skeptical of COVID-19 vaccine
LOS ANGELES — As scientists race to develop COVID-19 vaccines, a new poll shows less than two-thirds of Californians — and less than a third of the state’s Black residents — would be immunized if a vaccine was released today.
The poll results released Wednesday by the Public Policy Institute of California show that a majority of those surveyed, 57%, said they would either definitely or probably get a COVID19 vaccine if it were available today.
That opinion, however, was shared by only 29% of Black respondents — far below the 70% of Asian Americans, 62% of white people and 54% of Latinos who said they would definitely or probably get vaccinated.
Instead, 44% of Black residents said they would definitely not get the vaccine were it available today.
The findings are based on a survey of 1,701 California adults who were interviewed from Oct. 9 to 18. The survey has a margin of error of plus or minus 3.5 percentage points.
Though eye-catching and troubling for health officials developing a plan for disseminating a vaccine throughout the state, the
findings of the statewide survey didn’t come out of the blue.
The reluctance of Black people to get vaccinated against the virus that causes COVID-19, which has had a disproportionate impact on minorities, is rooted in a broader suspicion toward vaccines in general, according to some experts.
“I have no surprise because this is not just relevant in terms of COVID19,” said Vickie Mays, a professor of health policy and management in the UCLA Fielding School of Public Health. “We’ve seen this even in terms of other types of immunizations.”
The skepticism is likely driven in part by the repeated abuses and harmful practices Black Americans have been subjected to throughout history under the guise of medical research, researchers said.
Among the most odious examples was the notorious Tuskegee experiment — in which doctors used black men in Macon County, Ala., as unwitting test subjects, withholding treatment for syphilis, even long after a cure had been found.
The doubts among Black respondents mirror a broader suspicion. In another poll that the Public Policy Institute of California conducted in May of last year, for example, participants were asked whether parents should have to vaccinate their children for diseases like measles, mumps and rubella.
Among all adults, the response was a resounding yes — 73% to 26%. Black residents were far more split, however, with only 53% in favor of such a requirement.
Several other factors are at play as well, experts said.
In a recent study, researchers at USC found that 31% of Black Americans would be unwilling to pay anything for a hypothetical COVID-19 vaccine — a sentiment shared by 19% of whites, 22% of Hispanics and 6% of Asian Americans.
“While concerns over widespread adoption of a vaccine must address questions of safety and efficacy, we have found that cost is a significant dimension as well,” they wrote in their paper earlier this month. “Beyond this, though, we find that cost does not fully account for hesitancy toward a COVID-19 vaccine, especially among Blacks.”
Another source of suspicion — one that is felt across races — is the speed with which vaccine development is moving. Its expediency is reflected in the moniker chosen by the Trump administration: Operation Warp Speed.
Overall, 68% of respondents in the recent Public Policy Institute of California poll said they were more concerned with vaccine approval moving too fast, “without fully establishing it is safe and effective.” Only 26% expressed greater worry with the process progressing too slowly and “creating unnecessary delays in providing access.”
The poll’s findings show that health officials, politicians and community leaders will have to work hard to assure the state’s roughly 2.3 million Black residents that a vaccine, when ready, is safe, according to Mark Baldassare, survey director at the Public Policy Institute of California.
A key takeaway, he said Thursday, is “not to assume that, when a vaccine is available, everyone is going to be lining up for it and lining up for it equally.”
“It’s going to be very important to provide consistent information that it’s safe and it’s ready for widespread consumption and it’s necessary — and for people to hear this from sources that they believe in and that they trust,” he said.
The recent USC study also showed how “the pandemic’s disproportionate impact on communities of color further highlights the importance of prioritizing trust-building and transparency in the process of vaccine development and deployment.”
“We do eventually, clearly, want to disseminate a safe vaccine to everyone and all communities,” Burton said. “But there are going to be some real challenges, and this is one of them.”